Tatton Consulting supported Southwark-based digital health coaching company Holly Health in its successful application to Biomedical Catalyst 2023 Round 2: Industry-led R&D, which was awarded £445,342 by Innovate UK for the project Holly Health Prevent: Developing Precision Health Behaviour Change Product, using JITAI Coaching for Multimorbidity. The project’s total Innovate UK grant across all partners was £445,342.
About the funded R&D project
Around 30% of UK adults live with two or more long-term conditions, and multimorbidity accounts for roughly 70% of NHS health and social care expenditure. Of those adults, 34% have both physical and mental conditions, a combination that makes self-management considerably harder. Supported self-management reduces disease progression and service usage, but NHS capacity to deliver it is limited. The project develops precision behaviour change using just-in-time adaptive intervention coaching for multimorbidity.
Award details
- Total project grant: £445,342
- Of which to Holly Health: £307,535
- Competition: Biomedical Catalyst 2023 Round 2: Industry-led R&D
- Competition year: 2023/24
- Project: Holly Health Prevent: Developing Precision Health Behaviour Change Product, using JITAI Coaching for Multimorbidity
- Sector: Digital health / behaviour change
- UKRI project record: Gateway to Research, project 10102929
- Dataset: Innovate UK funded projects, published 10 August 2026
Tatton Consulting supported the competitive grant application. The award value, competition and project title above are taken from UKRI’s published record for this project.
See all Innovate UK awards Tatton Consulting has supported on our grant successes page.
